Anticoagulants in the Treatment of Pulmonary Thromboembolism During the Hospital Period: Recommendations, Possibilities, Approaches to Rational Choice. The Place of Fondaparinux

EMERGENCY MEDICINE
doi 10.22141/2224-0586.8.95.2018.155152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House Zaslavsky

Related search

Erratum To: Pharmacology of Anticoagulants Used in the Treatment of Venous Thromboembolism

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2016English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

The Choice of Treatment Tactics for Thromboembolism of the Pulmonary Artery of Medium-High Risk and Chronic Kidney Disease

Kardiologiya
Cardiovascular MedicineCardiology
2019English

Approaches to the Treatment of Diseases of the Lower Respiratory Tract: Choice of Antibacterial Preparati on Taking Into Account International Recommendations

ACTUAL INFECTOLOGY
2018English

Fondaparinux Reduces Thromboembolism in Elderly Medical Patients

BMJ
2006English

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs
Pharmacology
2014English

Derivation of the Non-Inferiority Margin for the Evaluation of Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2013English

Anticoagulants in Venous Thromboembolism.

BMJ
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy